Mechanisms of cancer-related fatigue.

  title={Mechanisms of cancer-related fatigue.},
  author={Julie L. Ryan and Jennifer Carroll and Elizabeth P. Ryan and Karen M. Mustian and Kevin A. Fiscella and Gary R. Morrow},
  journal={The oncologist},
  volume={12 Suppl 1},
Cancer-related fatigue (CRF) is one of the most prevalent symptoms patients with cancer experience, both during and after treatment. CRF is pervasive and affects patients' quality of life considerably. It is important, therefore, to understand the underlying pathophysiology of CRF in order to develop useful strategies for prevention and treatment. At present, the etiology of CRF is poorly understood and the relative contributions of the neoplastic disease, various forms of cancer therapy, and… 

Figures from this paper

Pathophysiology of cancer-related fatigue.

  • X. Wang
  • Biology, Psychology
    Clinical journal of oncology nursing
  • 2008
Pathophysiologic research in CRF could be applied in the clinic to improve CRF diagnosis and to enable administration of mechanism-driven interventions and a targeted intervention study with CRF as a primary end point also would be useful.

The pathophysiology of cancer-related fatigue: current controversies

A narrative review of the literature and current controversies in the pathophysiology of cancer-related fatigue are presented, particularly in relation to central and peripheral hypotheses for CRF.

Mechanisms of Cancer Related Fatigue

This chapter reviews the hypothesized mechanisms of fatigue and the strength of evidence for each and concludes that further evidence is needed to conclusively determine the mechanism of fatigue.

Cancer-Induced Fatigue and Cachexia

Research into the various hypotheses discussed in this chapter would greatly benefit cancer patients experiencing fatigue, including muscle wasting, involving both the degradation of muscle and the inhibition of muscle regeneration.

Fatigue in older cancer patients: etiology, assessment, and treatment.

There continues to be a need for randomized controlled trials (RCTs) evaluating CRF specifically in elderly patients with cancer and the areas of required research in this patient population are highlighted.

Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue.

An overview of current research on the relative merits of integrative nonpharmacologic behavioral interventions for the effective clinical management of cancer-related fatigue is provided and recommendations for future research are made.


Methylphenidate, modafi nil and guarana show the most promising results so far, however, additional randomized, placebo-controlled trials are needed to determine the benefi t of these and other drugs in the treatment of CRF.

Commonalities in the Features of Cancer and Chronic Fatigue Syndrome (CFS): Evidence for Stress-Induced Phenotype Instability?

Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) and Cancer-Related Fatigue (CRF) are syndromes with considerable overlap with respect to symptoms. There have been many studies that have

Cancer-related fatigue.

Methylphenidate, modafi nil and guarana show the most promising results so far, however, additional randomized, placebo-controlled trials are needed to determine the benefi t of these and other drugs in the treatment of CRF.



Management of Cancer-Related Fatigue

A more thorough evaluation of the various therapeutic options is required to better define their efficacy and safety profiles in this patient population.

Fatigue associated with cancer and its treatment

Four plausible hypotheses for the development of fatigue are introduced and evidence available to support a role for anemia, adenosine triphosphate, vagal afferents, and the interaction of the HPA/cytokines and 5HT is discussed.

Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome.

The neuroendocrinology of chronic fatigue syndrome.

  • A. Cleare
  • Psychology, Medicine
    Endocrine reviews
  • 2003
It is suggested that more prospective cohort studies be undertaken in groups at high risk for CFS, that patients with CFS are followed up into recovery, and that multidimensional assessments are undertaken to unravel the influence of the various confounding factors on the observed endocrine changes in CFS.

Exercise as an intervention for cancer-related fatigue.

Evidence from recent randomized clinical trials regarding the effectiveness of exercise as an intervention for cancer treatment-related fatigue is examined, findings from 8 recent RCTs are presented, 6 of which involved patients with breast cancer, and suggestions for exercise program protocols are provided.

Fatigue in neurological disorders

Distinguishing fatigue and depression in patients with cancer.

A consideration of causal mechanisms suggests why it remains difficult to distinguish between fatigue and depression, and recently developed diagnostic criteria for a clinical syndrome of cancer-related fatigue might be useful in identifying fatigue that is caused by a major depressive disorder for which antidepressant therapy is generally indicated.

Increased brain serotonin function in men with chronic fatigue syndrome

The increase in plasma prolactin after administration of the selective serotonin releasing agent d-fenfluramine was measured in men rigorously diagnosed as having the chronic fatigue syndrome and carefully matched healthy controls.

Fatigue, depression and quality of life in cancer patients: how are they related?

Fatigue is not a valid criterion for depression in cancer patients undergoing radiotherapy, nor is there a strong cause-and-ef- fect relationship, but both depression and physical fatigue are relevant to patients' quality of life.